Bill Kerr, M.D., MBA

home / authors / bill-kerr-m-d-mba

Articles

The Benefits and Challenges of Precision Medicine for Health Plans

The Benefits and Challenges of Precision Medicine for Health Plans

Bill Kerr, M.D., MBA
August 8th 2025

Precision medicine is transforming medicine but not as quickly as it could or should.

Read More

drawing of someone looking at microscope | image credit: ©elenabsl stock.adobe.com

Lab Claim Integrity: A Vital Component of Healthcare Quality and Cost Containment

Bill Kerr, M.D., MBA
May 8th 2025

As ubiquitous as lab testing is in healthcare, health plans still often overlook its importance to healthcare quality and cost containment.

Read More

Lab Power | Predictions for 2025

Lab Power | Predictions for 2025

Bill Kerr, M.D., MBA
January 17th 2025

A forecast of the year by Bill Kerr, M.D., MBA, CEO of Avalon Healthcare Solutions.

Read More

Latest Updated Articles

ZAKARIYAE-stock@adobe.com
Published: August 7th 2025 | Updated: August 14th 2025
FDA Grants Accelerated Approval For Targeted Drug for Rare Brain Tumor
FDA Approves First Treatment for Chronic Inflammatory Lung Condition
Published: August 12th 2025 | Updated: August 14th 2025
FDA Approves First Treatment for Chronic Inflammatory Lung Condition
Gaps in Diabetes Patient Education and Rising Healthcare Costs
Published: February 25th 2025 | Updated: February 28th 2025
Gaps in Diabetes Patient Education and Rising Healthcare Costs
black and white image of solders in jungle setting | ©daniel stock.adobe.com
Published: February 16th 2025 | Updated: February 19th 2025
Many Aging Vietnam War Vets Are Still Battling PTSD, Along With Chronic Illnesses, That Combat Exposure May Make More Likely, New Research Finds
food in heart shape with a stethoscope | image credit: ©udra11
Published: February 5th 2025 | Updated: February 7th 2025
A Key Ingredient to ‘Food is Medicine’: Standardization
Evernorth Drives Cigna's Strong Revenue Growth and Focuses on Biosimilars and Drug Affordability
Published: January 30th 2025 | Updated: January 31st 2025
Evernorth Drives Cigna's Strong Revenue Growth and Focuses on Biosimilars and Drug Affordability
© 2025 MJH Life Sciences

All rights reserved.